CRESCO LABS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.83 CAD | +3.66% |
|
-5.03% | +58.10% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 744M 1.02B | Sales 2025 * | 793M 1.09B | Capitalization | 697M 958M |
|---|---|---|---|---|---|
| Net income 2024 * | -30M -41.26M | Net income 2025 * | -38M -52.26M | EV / Sales 2024 * | 1.52 x |
| Net Debt 2024 * | 432M 594M | Net Debt 2025 * | 451M 620M | EV / Sales 2025 * | 1.45 x |
| P/E ratio 2024 * |
-29.8
x | P/E ratio 2025 * |
-28.1
x | Employees | 2,760 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.14% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cresco Labs Inc.
More recommendations
More press releases
More news
| 1 week | -19.71% | ||
| Current month | -19.71% | ||
| 1 month | -10.49% | ||
| 3 months | -13.88% | ||
| 6 months | +72.78% | ||
| Current year | +52.51% |
1 week
2.73
3.15
1 month
2.603.58
Current year
1.773.58
1 year
1.353.78
3 years
1.3515.90
5 years
1.3522.20
10 years
1.3522.20
| Managers | Title | Age | Since |
|---|---|---|---|
Charles Bachtell
FOU | Founder | 45 | 15-01-31 |
Gregory Butler
PSD | President | 44 | - |
Dennis Olis
DFI | Director of Finance/CFO | 61 | 20-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
John Walter
BRD | Director/Board Member | 76 | 17-02-28 |
Carol Vallone
BRD | Director/Board Member | 67 | - |
| Chairman | 68 | 12-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 0 M€ | -1.79% | - | |
| 0.00% | 0 M€ | -1.96% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 2.83 | +3.66% | 94 470 |
| 24-05-07 | 2.73 | -4.21% | 152,856 |
| 24-05-06 | 2.85 | -3.72% | 240,294 |
| 24-05-03 | 2.96 | +0.68% | 153,099 |
| 24-05-02 | 2.94 | -1.34% | 131,532 |
Delayed Quote Canadian Securities Exchange, May 07, 2024 at 03:59 pm EDT
More quotes
Cresco Labs Inc. is an integrated multi-state cannabis operator in the United States. The Company is licensed to cultivate, manufacture, and sell retail and medical cannabis products primarily through Sunnyside, Cresco Labsâ national dispensary brand, and third-party retail stores. Its family brands include Cresco, High Supply, Good News, Wonder Wellness Co., FloraCal Farms, Remedi and Mindyâs. Its portfolio consists of over 400 products. The Company's products are sold in over 1,600 dispensaries across the country. Its Cresco offers consistent strains, available in a variety of product forms at dispensaries and retail locations nationwide. Its High Supply lab-tested; and available in vape carts, vape pens, flower, popcorn, shake, shorties and concentrates. Its Remedi products provide a consistent and trusted alternative to traditional pharmaceuticals like opioids. Its Mindyâs offers dosed edibles created by James Beard. It is the wholesaler of branded cannabis products.
Sector
Pharmaceuticals
Calendar
2024-05-14
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
1.993
USD
Average target price
4.363
USD
Spread / Average Target
+118.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +52.51% | 697M | |
| +33.43% | 700B | |
| +27.62% | 569B | |
| -5.12% | 358B | |
| +19.59% | 330B | |
| +4.89% | 287B | |
| +16.08% | 236B | |
| +6.53% | 202B | |
| -9.37% | 197B | |
| +4.26% | 161B |
- Stock Market
- Equities
- CL Stock